中国组织工程研究与临床康复第13卷第5期2009–01–29出版JournalofClinicalRehabilitativeTissueEngineeringResearchJanuary29,2009Vol.13,No.5ISSN1673-8225CN21-1539/RCODEN:ZLKHAH988DepartmentofOrganTransplantation,JiangxiProvincialPeople’sHospital,Nanchang330006,JiangxiProvince,ChinaLuoWen-feng★,Master,Attendingphysician,DepartmentofOrganTransplantation,JiangxiProvincialPeople’sHospital,Nanchang330006,JiangxiProvince,Chinakelvinf@126.comReceived:2008-08-04Accepted:2008-11-17(54200808040004/G)LuoWF,ShiJ,MengDL,LiXC,XuZD,LongCM.Combinedliver-kidneytransplantationinonecase.ZhongguoZuzhiGongchengYanjiuyuLinchuangKangfu2009;13(5):988-990(China)[http://www.crter.cnhttp://en.zglckf.com]Combinedliver-kidneytransplantationinonecase★LuoWen-feng,ShiJun,MengDong-liang,LiXin-chang,XuZhi-dan,LongCheng-meiAbstract:A32-yearoldmalewhohadlivercirrhosisaccompanyingwithchronicrenalinsufficiency(uremia)wassufferedfromhomochronousallografttransplantationofliver-kidney.Thebloodandothertissuetypingwereinconcordbetweenthedonorandrecipient.Thelivertransplantationtooktypicalorthotopictransplantationtechniquewhilethekidneytransplantationtookgeneraloperationmethodtoplacethetransplantedkidneyattherecipient’srightiliacfossa.Daclizumabwastakenfortheimmunityinductiontreatmentbeforetransplantationwhilethetrigeminyoftacrolimus+mycophemocatemofeil+methylprednisoloneweretakenasimmunosuppressantaftertransplantation.Thetransplantedliverandkidneyrecoveredwellwhichcouldworkatoncewithoutanyseriouscomplicationsaftertransplantation,suggestingthatcombinedliver-kidneytransplantationwasaneffectivetreatmentmethodforhomochronousfunctionfailureofliverandkidneycharacterizingbyperfecttissuetyping,excellentoperationskill,reasonableusageofimmunosuppresantbeingthekeypointofsuccessfortransplantation.INTRODUCTIONThefirstworldwidecombinedliver-kidneytransplantationwasoperatedatInnsbruckUniversitybyMargreiteretal[1]on28thDecember1983,whichgotpreferableeffectafteroperation.Fromthen,combinedliver-kidneytransplantationwaswidelyconductedasafeasibletreatmentmeansforsimultaneousliver-kidneyfailurebyorgantransplantationcenterintheworld.Bothofirreversibleliver-kidneyfunctionalimperfectionandfailurecausedbyanycasesareindispensabletocombinedliver-kidneytransplantation.Ourhospitalfinishedonecaseofcombinedliver-kidneytransplantationsuccessfullyon13thJune2006.CASEINFORMATIONStatusoftherecipientAmale,aged32years,wentunderhospitalizationhalfyearlaterwhendiagnosedthatsufferingchronicrenalinsufficiency(uremiaphase)and10yearsmoreofhepatocirrhosis,hadeverinfectedschistosomiasis,nohepatitis,uppergastrointestinalbleedingrepeatedlytogetherwithascites.Therecipientundertookthesplenectomyin1997duetospleenintumescenceandhyperspleniacausedbyportalhypertension.Meanwhile,withdailyurinevolumeof200-300mL,hehasbeenunderhemodialysisfromlatertimeof2005at1-2timesperweek.Alloftheexamreportsindicatedthattherecipientwasinseriousanaemia,ascites,andhypoproteinemia,aswellasroseofalanineaminotransferaseandaspartateaminotranserase,withserumcreatininelevelat1266μmol/Landurineproteinat+++.Withwhichthefinaldiagnosisresultishepatocirrhosis(decompensationphase)andchronicrenalinsufficiency(uremiaphase).StatusofdonorThedonorwasyoungwhoseliverandkidneywerewellworkedwhichobtainedbyinstantcombinedorganresectionmethodwith5-minutewarmischemia,9-hourcoldischemiaforliver,and18-hourcoldischemiaforkidneyfromthesamecorpse(typeOblood,negativePRAoftherecipient,threemismatchedHLAtypes,and5%lymphoustoxicity),andthebloodgroupaswellasothertissuetypingmatchedwellwiththerecipient’s.StatusofoperationItwasoperatedundergeneralanaesthesiaandnonby-passoperation.Theoperationbeganwithlivertransplantationunder8hourswhichtooktypicalorthotopicallivertransplantationandfollowedbykidneytransplantationunder2hourswhichtooknormalwaythattotransplantthedonatedkidneyintotherecipient’srightiliacfossa.50mgdaclizumabwasappliedtoimmunitytemptationatthestageofpre-operationwhile500mgmethylprednisoloneusedforanti-rejectionduringoperationand100mgfurosemidetakenfordiuresisafteroperation.Thewholetransplantationprocesswentquitesuccessfully,andthetransplantedliverandkidneyworkedwellatonce,bilewasinidealsituation,whileurineflewoutfromitsureter1minuteaftertheveinoftransplantedkidneyopened.TreatmentafteroperationTherespiratorwastakenawayandtheendotrachealtubewaspulledout17hoursafteroperation,atthesametime,anti-infection,anti-rejection,livercaring,jaundicelevelandenzymereductiontogetherwithgastricacidrestraint,etc.weretakenatthestageofpost-operation.While,tacrolimus+mycophemolatemofeil+methylprednisolonewastakenasimmunosuppresant.Furthermore,vitalsign,bloodsugar,bloodgasanalysis,T-cubedrainagevolume,electrolyte,bloodrule,urinevolume,liver-kidneyfunction,blooddruglevelofTacrolimus,colorDoppler,etc.werestrictlymonitored.RESULTSTherecipientrecoveredwellaftertransplantationastheliver-kidneyfunctionwentsuccessfully,withnoseriousneopathyandrejection.Thebiliarydrainagevolumegraduallyincreasedto300-500mLoneday,whiletheurinevolumereached3000-4000mLoneClinicalMedicineLuoWF,etal.Combinedliver-kidneytransplantationinonecaseISSN1673-8225CN21-1539/RCODEN:ZLKHAH989www.CRTER.orgday,therecipientdischargedfromhospitalatthetimeofabout3monthsafteroperation.Withnojaundiceandbeingcapableofdealingwithdailylifehedischargedfromhospitalundertheconditionthatliver-kidneyfunctionbasicallyrecovered,serumcreatinineandureanitrogenlevergottonormalstatus.Clinicfollowing-upvisitservicehasbeendonefromthenon.Thepatientinfectedpulmonarytuberculosis(TB)atthetimeof4monthafteroperationduetothecloselivingwithpulmonaryTBinfectedfamilymembers.Rifampicin(for1year),isoniazid(for1year),pyrazinamide(for2months)andstreptomycin(for2months)weretakentodothetreatmentofanti-TB,sofarthesymptomhasbeenrestrainedandgotidealeffect.Therecipient’sliver-kidneyfunctionworkedwellandhasbeensurvivedfor14monthsbasedontheinformationfromclinicfollowing-upvisitservice.DISCUSSIONIndicationofcombinedliver-kidneytransplantationInbornorheritagediseasewhichinvolvedwithliverandkidneysimultaneously,suchasinbornpolycysticliverorpolycystickidney;heritageandmetabolicdiseaseaccompanywithrenalfunctioncontamination,primaryhyperoxaluriatypeⅠforinstance;thiscategoryofpatientthatwithdifferentetiopathogenisisinvolveswithliver-kidneythistwoorganstakeslargepercentageincombinedliver-kidneytransplantation,andthisrecipientbelongedtothistype.Itisstilluncertain[2]thatwhethertheliver-kidneysyndromeistheindicationofcombinedliver-kidneytransplantationornot.Forthereasonthatrenalfunctioncontaminationcausedbyliverfailureseemsmostlytemporaryorfunctionalsincetherenalfunctioncanrecoveroncetheliverfunctionbecomewellworkedgradually.However,thisseveralyearssomeresearcherhasfoundthatsometimestheproofoforganicdiseasefrompathology’spointofviewcanbefoundsimultaneouslyforpatientwhosufferingfromliverfailureandkidneyfunctioncontamination,suchasdepositionofimmunecomplex,kidneystromachange,etc[3].Furthermore,forunstablehemodynamicsduringandaftersimplelivertransplantation,bloodloss,massivetransfusion,infectionandtheapplicationofrenaltoxicityimmunosuppressant,etc.whichusuallycauseacuterenalfailureandneedtoundertakedialysis&kidneyre-transplantation[4].Therefore,someoftransplantationcentersregardliver-kidneysyndromeastheimplicationofcombinedliver-kidneytransplantation.ImmunoprotectionofthetransplantedliveruponthetransplantedkidneyThiskindofimmunoprotectioneffecthasbeenjustifiedfromtheanimalexperimentatveryearlytime.Itwasalsofoundthattheliverincombinedliver-kidneytransplantationcanreducetherejectionrateandprolongthesurvivingtimeofthetransplantedkidney[5].ResearchdidbyLangetal[6]indicatedthatitdoesnotmakemuchinfluenceonpatientandtransplantedorganlong-termsurvivalratiofortheincompatibletissuetypingofdonorandrecipientwhomoperatedcombinedliver-kidneytransplantation.Thisisbecausetheliverprotectsthekidneyasanimmunityfavororganbyitsimmunoprotectioneffect.Whilethetransplantedkidneydoesnotbringanythatsamebenefitforthetransplantedliver,thiskindofimmnoprotectionsystemisstilluncertain,whichgotsomeacademictheoryasantigencapture,solubleantigenliberation,micro-gomphosisassumption,etc[7].Thisrecipientdidnotsufferfromrejectionduringoperationaswellas14monthsafteroperation,andthesurvivalconditionofthetransplantedkidneyisquitefine.TissuetypingItisfortheliver’simmunoprotectionuponthekidneythatstillmakescombinedliver-kidneytransplantationrealizableeveniftheclinictissuetypingfailsforthedonorandrecipient,whilethissituationisdefinitelynotallowedforsimplykidneytransplantation.Sincethetissuetypingfailureisnotthecounterindicationofcombinedliver-kidneytransplantationanymorewhilewhichwouldinfluencetheprognosisofthetransplantedkidney,itispreferabletodothetransplantationbetweenthequalifiedtissuetypingdonorandrecipientwhenotherconditionisallowable.Thecaseabovementionedisqualifiedtissuetyping[8].Thecaseherebymentionedgotqualifiedtissuetyping.OperativemethodsandtechniquesSurgicaloperationmethodsisthesameasthesimplyliverorkidneytransplantation.Whileregardingwiththeorder,livertransplantationshouldbedonebeforekidneyoperation.Thisisforthereasonthatkidneyismuchmorecapableofenduringcoldischemiainjurywhilethetransplantedliverwillapplyitsimmunoprotetiontothelatertransplantedkidney,ifdotheoperationbyoppositeorderthenthebleedingoflivertransplantationwillcauseunstablehemodynamics,whichisquiteharmfulforthebloodstreamperfusionofkidneytransplantationandledtoischemiainjury.Onthecontrast,bydoinglivertransplantationearlierthankidneytransplantationwillmakesuretheidealeffectofbloodstreamperfusionofkidneytransplantation.Itcanreducetheneopathyoflungembolism,bleedingundernonby-passoperation;however,skillfulperformance,timereductionandanhepaticphaseshorteningarerequestedforthiskindofcondition.Itisextremelyimportanttocontrolthebloodpressureforcombinedliver-kidneytransplantation,relativelowerbloodpressureforlivertransplantationisbenefitfordecreasingbleedingandcapillaryofwoundsurface,whilerelativehigherbloodpressureforkidneytransplantationisquitehelpfulformakingsurethequalityofkidneybloodstreamperfusion,whichwesupposetodefinethesystolicpressuretoaround130mmHg(1mmHg=0.133kPa)asidealcondition.ApplicationofimmunosuppressantImmunitycatastaltictreatmentofcombinedliver-kidneytransplantationusuallytaketrigeminyofciclosporin/tacrolimus+mycophemocatemofeil+methylprednisolone/prednisone,meanwhile,strengtheningtheinductiontreatmentatearlytime[9-10].Bothofciclosporinandtacrolimushasrenaltoxicity,whichmustbecarefullyusedbeforetherecoveryofrenalfunction,whichismuchsafertouseoncetheurinecomesout.Theusageofimmunityinductiontreatmentcanwellpreventtherejection.Inthisoperation,wetookdaclizumabtocarryouttheimmunityinductiontreatment,andtooktrigeminyoftacrolimus+mycophemocatemofeil+methylprednisolonetoresistrejectionatthetimeofgettingidealurinevolumeafteroperation,whichLuoWF,etal.Combinedliver-kidneytransplantationinonecaseP.O.Box1200,Shenyang110004cn.zglckf.com990www.CRTER.orgturnedouttobeeffectivetreatmentsincetherewasnoanyrejectionoccurredduringandafteroperation.REFERENCES[1]MargreiterR,KramarR,HuberC,etal.Combinedliverandkidneytransplantation.Lancet.1984;1(8385):1077.[2]JeyarajahDR,GonwaTA,McBrideM,etal.Hepator-renalsyndrome:combinedliverkidneytransplantationversusisolatedlivertransplantation.Transplantation.1997;64:1760.[3]WangHH，ChengZS.Combinedliver-kidneytransplantation.LinchuangWaikeZazhi.2006;14(6):388.[4]QiuZJ,PengZH,QiXS.15casesreportofcombinedliver-kidneytransplantation.ZhonghuaQiguanYizhiZazhi.2005;26(6):322.[5]BeckerBN,OdoricoJS,BeckerYT,etal.Simultaneouspancreaskidneyandpancreastransplantation.JAmSocNephrol.2001;12(11):2517.[6]LangM,NeumannU,KahlA,etal.Combinedliverandkidneytransplantation:indicationsandlong-termfollow-up.ChirUrg.2001;72(10):1154.[7]XiaP,ZhangQY,YangYR,etal.Theprotectioneffectofliveruponkidneyincombinedliver-kidneytransplantation.GandanyiWaikeZazhi.2003;15(2):108.[8]ZhengSS.LiverTransplantation.Beijing:People’sHealthPublishingCompany.2003:435.[9]PengZH,XiaQ,XuD,etal.Onecaseofcombinedliver-kidneytransplantation.ZhonghuaPutongWaikeZazhi.2003;18(2):121.[10]LiuYF,LiuSR,LJ,etal.Combinedpancreas-kidneytransplantationtreatmentfordiabetesmellitusandwhichinvolveswithdiabeticnephropathy.ZhonghuaGandanWaikeZazhi.2003;9(5):296.肝肾联合移植1例报告★罗文峰，时军，孟栋良，李新长，徐志丹，龙成美(江西省人民医院器官移植科，江西省南昌市330006)罗文峰★，男，1974年生，江西省新余市人，汉族，1998年南昌大学医学院（原江西医学院）毕业，硕士，主治医师，主要从事器官移植、普外科研究。摘要:对1例32岁的肝硬化并慢性肾功能不全（尿毒症期）受体施行一期同种异体肝肾联合移植。供受体血型等组织配型相匹配，肝移植采用经典的原位移植技术，肾移植采用常规移植方法，将移植肾置于右髂窝。移植前予以赛尼哌行免疫诱导，移植后采用他克莫司+吗替麦考酚酯+甲强龙三联疗法进行免疫抑制治疗。受体移植后肝肾立即发挥作用，移植后无严重手术并发症发生，移植肝肾功能恢复良好。提示肝肾联合移植是治疗肝肾同时衰竭的有效方法，良好的组织配型、完善的移植技术、免疫抑制剂的合理使用及移植后并发症的正确处理是移植成功的关键。关键词：肝；肾；联合移植；器官移植中图分类号:R617文献标识码:B文章编号:1673-8225(2009)05-00988-03罗文峰，时军，孟栋良，李新长，徐志丹，龙成美.肝肾联合移植1例报告析[J].中国组织工程研究与临床康复,2009,13(5):988-990[http://www.crter.orghttp://cn.zglckf.com](EditedbyLiW/JiH/WangL)医学界的很多研究人员经历了艰辛的努力与劳动，观察和得到了很多首发或验证性的有意义的实验结果，这些结果如果能够抢先发表在国际相关的学科杂志上，不仅会得到学科界的认可，而且有利于扩大和提升作者科研成果的价值，确定作者进一步深入开展此项实验的意义。但鉴于语言习惯问题，大多数稿件都会因语言问题而被退回。本刊长期从事生物医学稿件编辑工作又与国际英文编辑机构有良好的合作，沟通，故开展此项服务工作。如您或您的同事、同学、学生正因为英语言表述问题而苦恼于向国际相关期刊投稿，可与本刊联系，本刊可为国际投稿作者提供相关服务，并可保证英文的表述质量。E-mail:bwb_001@crter.org咨询电话:024-23380579ISSN1673-8225CN21-1539/R2009年版权归《中国组织工程研究与临床康复》杂志社所有CRTER为国际投稿作者服务
